Prevalence of self-report photosensitivity in cutaneous lupus erythematosus Kristen Foering, BS, Renato Goreshi, MD, Rachel Klein, MD, Joyce Okawa, RN,

Slides:

Advertisements

Similar presentations

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Advertisements

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

A girl with a solitary red bulla

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Psoriasis: Latitude does make a difference

Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: Report of three cases Xiaoqing.

Sweet's panniculitis associated with metastatic breast cancer

Baldness reversed by chemotherapy

Efficacy of simvastatin in plaque psoriasis: A pilot study

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

Efficacy of topical application of eosin for ulcerated hemangiomas

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Pediatric teledermatology: Observations based on 429 consults

JAK inhibitors in dermatology: The promise of a new drug class

Larissa A. Chismar, MD, Nicole Umanoff, BS, Blair Murphy, BS, Kate V

Katherine E. Brick, BS, Robert H. Cook-Norris, MD, David A

Khanh P. Thieu, BS, Harley A. Haynes, MD

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Smoking and risk of psoriasis: A nationwide cohort study

Pilot study of a skin cancer education curriculum for medical students

Applying for dermatology residency is difficult and expensive

Kishore L. Jayakumar, BS, Sara S. Samimi, MD

Pain and nonmelanoma skin cancer in transplant patients

Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection Alberto Conde-Taboada, MD, Javier Pedraz Muñoz, MD, Lucía.

Chauncey C. Caldwell, MD, Sami K. Saikaly, MD, Robert P

Reply to: “A note on normality”

Vitamin D deficiency in patients with chronic and acute urticaria: A systematic review and meta-analysis Tsung-Yu Tsai, MD, Yu-Chen Huang, MD Journal.

Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.

Dermatomyositis: A diagnostic dilemma

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss Elise A. Olsen, MD, Douglas Canfield, BS Journal.

Increased serum levels of interleukin 33 in patients with atopic dermatitis Risa Tamagawa-Mineoka, MD, PhD, Yasutaro Okuzawa, MD, Koji Masuda, MD, PhD,

Infectious rash after riding elephants

Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial Lauren Okon, MD, Misha Rosenbach, MD, Michael.

Robert Kantor, BS, Prarthana Dalal, BS, David Cella, PhD, Jonathan I

Transdermal Fentanyl for Chronic Pain in AIDS

Cutaneous fungal infections are commonly misdiagnosed: A survey-based study Ramsin Joseph Yadgar, BS, Neal Bhatia, MD, FAAD, Adam Friedman, MD, FAAD

Lip edema Journal of the American Academy of Dermatology

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Meera Tarazi, BA, Kumpol Aiempanakit, MD, Victoria P. Werth, MD

Study Designs in Patient-Oriented Research

Hugh Gloster, MD, Chesahna Kindred, MBA

Seasonal patterns in alopecia areata, totalis, and universalis

Medicaid acceptance among pediatric dermatologists

Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients Feriel Fennira, MD, François Chasset, MD, Martin Soubrier,

Pruritus severity in patients with psoriasis is not correlated with psoriasis disease severity David Roblin, MD, FRCP, Ro Wickramasinghe, PhD, MBA, Gil.

Jennifer L. Hundley, MD, Christie L

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Kristen Foering, MD, Aileen Y. Chang, MD, Evan W

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Derek Y. Hsu, BA, Kenneth Gordon, MD, Jonathan I

Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T

A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.

Leprosy masquerading as lupus

An open-label study evaluating the efficacy and tolerability of alefacept for the treatment of scalp psoriasis James Krell, MD, FAAD, Candi Nelson, BS,

Eyebrow transplantation: Alternative body sites as a donor source

Gaps in pain management in dermatology: A needs assessment from Canada

Deficiency of sun protection advertising exists in consumer magazines across demographic groups and varies by target demographic Lauren E. Wiznia, MD,

Numerous hyperpigmented macules of the oral mucosa

Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: A randomized, vehicle-controlled, double-blind.

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Deede Y. Liu, MD, Muhammad I. Gul, BS, Jo Wick, PhD, Anand N

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Photosensitive lichenoid drug eruption to capecitabine

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Presentation transcript:

Prevalence of self-report photosensitivity in cutaneous lupus erythematosus Kristen Foering, BS, Renato Goreshi, MD, Rachel Klein, MD, Joyce Okawa, RN, Mathew Rose, MS, Andrew Cucchiara, PhD, Victoria P. Werth, MD Journal of the American Academy of Dermatology Volume 66, Issue 2, Pages 220-228 (February 2012) DOI: 10.1016/j.jaad.2010.12.006 Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Prevalence of photosensitivity (PS) within each lupus erythematosus (LE) type. More than 75% of patients with acute cutaneous LE (ACLE), subacute cutaneous LE (SCLE), and more than one cutaneous LE (CLE) subtype (comprising mostly SCLE + another type of CLE) were PS whereas patients with discoid LE (DLE) were least PS with prevalence of 45%. CCLE, Chronic CLE; LET, tumid LE; SLE, systemic LE. Journal of the American Academy of Dermatology 2012 66, 220-228DOI: (10.1016/j.jaad.2010.12.006) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 Mean scores for photosensitivity (PS) items of modified Skindex-29+3. Mean scores (mean + SEM) for PS items and PS subscale by PS grouping. Significant differences between PS and ∗not-PS or #PS-suggestive groups; P < .05 with Bonferroni correction after analysis of variance. Journal of the American Academy of Dermatology 2012 66, 220-228DOI: (10.1016/j.jaad.2010.12.006) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions

Fig 3 Mean modified Skindex-29+3 subscale scores between photosensitivity (PS) and not-PS group. Mean scores (mean + SEM) for modified Skindex-29+3 subscales (emotion, symptoms, functioning). ∗PS group scored worse on all 3 subscales of modified Skindex-29+3 with P < .05. Journal of the American Academy of Dermatology 2012 66, 220-228DOI: (10.1016/j.jaad.2010.12.006) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions

Fig 4 Mean modified Skindex-29+3 subscale scores across high/low photosensitivity (PS) groups and mild/moderate-severe activity strata. Mean scores (mean + SEM) for modified Skindex-29+3 subscales (emotion, symptoms, functioning). ∗∗High PS group scored worse than low PS group within each disease activity strata on all 3 subscales of modified Skindex-29+3 with P < .01. #Mild activity, high PS group scored worse than moderate-severe activity, low PS group with P = .01. ns, Not significant. Journal of the American Academy of Dermatology 2012 66, 220-228DOI: (10.1016/j.jaad.2010.12.006) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions